Bismuth Subcitrate, Metronidazole, and Tetracycline and Necitumumab Intravenous
Determining the interaction of Bismuth Subcitrate, Metronidazole, and Tetracycline and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bismuth subcitrate potassium / metronidazole / tetracycline
Brand name: Pylera
Synonyms: Bismuth subcitrate potassium, metronidazole, and tetracycline
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bismuth Subcitrate, Metronidazole, and Tetracycline-Necon
- Bismuth Subcitrate, Metronidazole, and Tetracycline-Necon 0.5/35
- Bismuth Subcitrate, Metronidazole, and Tetracycline-Necon 1/35
- Bismuth Subcitrate, Metronidazole, and Tetracycline-Necon 1/50
- Bismuth Subcitrate, Metronidazole, and Tetracycline-Necon 1/50 (28)
- Bismuth Subcitrate, Metronidazole, and Tetracycline-Necon 7/7/7
- Necitumumab Intravenous-Bismuth Subgallate
- Necitumumab Intravenous-Bismuth subsalicylate
- Necitumumab Intravenous-Bismuth Subsalicylate Chewable Tablets
- Necitumumab Intravenous-Bismuth Subsalicylate Suspension
- Necitumumab Intravenous-Bismuth Subsalicylate Tablets
- Necitumumab Intravenous-Bismuth subsalicylate, metronidazole, and tetracycline